Clinical Significance of Molecular Streptococcus agalactiae Detection in Suspected Pneumonia
Overview
This retrospective study evaluated the clinical interpretation of Streptococcus agalactiae (GBS) detected by the BIOFIRE Pneumonia Panel in adults with suspected pneumonia. GBS was considered a pneumonia pathogen in approximately 48% of cases, but its clinical significance remains uncertain due to frequent codetection with other microorganisms and low culture positivity.
Background
Streptococcus agalactiae, or group B Streptococcus (GBS), is primarily known for neonatal and puerperal infections but has increasingly been reported in nonpregnant adults with diverse invasive infections including pneumonia. Pneumonia caused by GBS is uncommon but associated with high mortality, often occurring in patients with comorbidities. The BIOFIRE Pneumonia Panel is a multiplex molecular assay that detects multiple pneumonia pathogens including GBS, but distinguishing colonization from true infection is challenging due to GBS's presence in the upper respiratory tract.
Data Highlights
Parameter
Pathogen Group (GBS as pathogen)
Nonpathogen Group (GBS as colonizer)
Number of cases
52 (47.7%)
57 (52.3%)
ID consultation performed
33.0% overall; 30.6% considered GBS pathogen
---
Endotracheal intubation rate
51.9%
50.9%
In-hospital mortality
21.2%
14.0%
GBS culture positivity
10.2% of BF-PP GBS-positive specimens
---
Codetection with other microorganisms
76.1% (most commonly Staphylococcus aureus)
---
Key Findings
GBS was interpreted as a pneumonia pathogen in 47.7% of cases with BF-PP detection.
In 76.1% of cases, GBS was codetected with other microorganisms, frequently Staphylococcus aureus.
Only 10.2% of BF-PP GBS-positive respiratory specimens were culture positive for GBS.
Endotracheal intubation rates were similar between pathogen and nonpathogen groups (~51%).
In-hospital mortality was numerically higher in the pathogen group (21.2%) compared to the nonpathogen group (14.0%), but this difference was not statistically significant.
Infectious diseases consultation occurred in one-third of cases and influenced pathogen interpretation.
Clinical Implications
Detection of GBS by molecular methods in respiratory specimens should be interpreted cautiously, considering the high rate of codetection with other pathogens and low culture confirmation. Clinicians should integrate clinical, radiographic, and microbiological data, including infectious diseases consultation when available, to determine the significance of GBS in suspected pneumonia. Molecular detection alone may not reliably distinguish colonization from true infection.
Conclusion
While GBS is an established but uncommon pneumonia pathogen, its detection by the BIOFIRE Pneumonia Panel often reflects colonization or polymicrobial infection, underscoring the need for careful clinical correlation to guide management.
References
Mayo Clinic Study 2020-2025 -- Evaluation of the Clinical Importance of Detecting Molecular Streptococcus agalactiae in Patients with Suspected Pneumonia
